Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM

NCT03213002 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
67
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Northwell Health